PapersFlow Research Brief
Chronic Disease Management Strategies
Research Guide
What is Chronic Disease Management Strategies?
Chronic Disease Management Strategies are epidemiological and clinical approaches to assess, quantify, and address multimorbidity in patients with multiple chronic conditions, particularly through comorbidity indices, administrative data coding, and patient-centered care adaptations in primary settings.
The field encompasses 53,439 papers on the prevalence, healthcare utilization, and quality of life impacts of multimorbidity, especially among older adults. Key developments include comorbidity indices like the Charlson method for prognostic classification in longitudinal studies. Recent validations show updated indices maintain predictive power for risk adjustment across datasets from six countries.
Topic Hierarchy
Research Sub-Topics
Epidemiology of Multimorbidity
This sub-topic covers prevalence, incidence, and trajectories of multimorbidity clusters in aging populations using cohort and registry data. Researchers investigate demographic, socioeconomic, and regional variations in multiple chronic condition patterns.
Comorbidity Indices and Risk Adjustment
Studies develop, validate, and update indices like Charlson and Elixhauser for administrative databases across ICD versions. Researchers focus on predictive accuracy for mortality, readmissions, and costs in multimorbid patients.
Healthcare Utilization in Multimorbidity
This sub-topic examines patterns of hospitalizations, primary care visits, polypharmacy, and costs attributable to patient complexity. Analyses use multilevel modeling to disentangle interactions between conditions and service use.
Quality of Life in Multimorbid Patients
Researchers assess health-related quality of life using instruments like EQ-5D and SF-36, exploring physical, mental, and social dimensions affected by condition interactions. Studies identify predictors and interventions for QoL preservation.
Clinical Guidelines for Multimorbidity
This sub-topic addresses adaptations of single-disease guidelines for complex patients, prioritization frameworks, and deprescribing strategies. Researchers evaluate guideline concordance and barriers in primary care settings.
Why It Matters
Comorbidity measures enable precise risk adjustment in hospital discharge abstracts, as Quan et al. (2011) demonstrated by updating the Charlson Comorbidity Index using data from six countries, improving mortality predictions amid advances in chronic disease treatments. In administrative databases, Deyo (1992) adapted the Charlson index for ICD-9-CM, facilitating analysis of multimorbidity's effects on outcomes like healthcare utilization. Barnett et al. (2012) quantified multimorbidity epidemiology in a cross-sectional study, revealing its prevalence and implications for primary care, where patient complexity drives higher service demands and necessitates tailored clinical guidelines.
Reading Guide
Where to Start
Start with 'A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation' by Charlson et al. (1987), as it introduces the foundational Charlson Comorbidity Index with clear weighting methodology for prognostic assessment in longitudinal data.
Key Papers Explained
Charlson et al. (1987) established the original prognostic comorbidity index, which Deyo (1992) adapted for ICD-9-CM administrative databases to enable population-level analyses. Quan et al. (2005) extended this with ICD-10 algorithms that match ICD-9-CM estimates and outperform priors, while Elixhauser et al. (1998) proposed alternative measures emphasizing independent comorbidity effects. Quan et al. (2011) built on Charlson by updating and validating it across six countries' data, addressing changes in disease management impacts.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent validations like Quan et al. (2011) highlight needs to adjust indices for modern treatments reducing comorbidity mortality contributions. Cross-sectional epidemiology from Barnett et al. (2012) points to ongoing challenges in primary care multimorbidity management, with no new preprints available to indicate current developments.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | A new method of classifying prognostic comorbidity in longitud... | 1987 | Journal of Chronic Dis... | 48.6K | ✕ |
| 2 | Adapting a clinical comorbidity index for use with ICD-9-CM ad... | 1992 | Journal of Clinical Ep... | 10.4K | ✕ |
| 3 | Coding Algorithms for Defining Comorbidities in ICD-9-CM and I... | 2005 | Medical Care | 10.2K | ✕ |
| 4 | Comorbidity Measures for Use with Administrative Data | 1998 | Medical Care | 9.6K | ✕ |
| 5 | IDF Diabetes Atlas: Global, regional and country-level diabete... | 2021 | Diabetes Research and ... | 8.8K | ✓ |
| 6 | Epidemiology of multimorbidity and implications for health car... | 2012 | The Lancet | 6.8K | ✓ |
| 7 | Factors associated with COVID-19-related death using OpenSAFELY | 2020 | Nature | 6.5K | ✓ |
| 8 | The MOS social support survey | 1991 | Social Science & Medicine | 6.5K | ✕ |
| 9 | Global, regional, and national incidence, prevalence, and year... | 2015 | The Lancet | 6.4K | ✓ |
| 10 | Updating and Validating the Charlson Comorbidity Index and Sco... | 2011 | American Journal of Ep... | 5.6K | ✓ |
Frequently Asked Questions
What is the Charlson Comorbidity Index?
The Charlson Comorbidity Index, developed by Charlson et al. (1987) in 'A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation', assigns weights to chronic conditions based on their association with one-year mortality risk. It has been validated for use in longitudinal studies to predict patient prognosis. The index remains a standard for adjusting comorbidity in epidemiological research.
How are comorbidities coded in administrative data?
Quan et al. (2005) in 'Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data' developed algorithms that produce similar comorbidity prevalence estimates across ICD-9-CM and ICD-10. These algorithms outperform some prior ICD-9-CM methods in hospital data. Elixhauser et al. (1998) in 'Comorbidity Measures for Use with Administrative Data' proposed measures with independent effects on outcomes, avoiding oversimplification into a single index.
What are the implications of multimorbidity for healthcare?
Barnett et al. (2012) in 'Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study' showed multimorbidity increases with age and affects healthcare utilization and quality of life. It poses challenges in primary care due to patient complexity. Patient-centered approaches and adapted clinical guidelines are needed to manage these complex needs.
How has the Charlson Index been updated?
Quan et al. (2011) in 'Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries' reevaluated the index, finding chronic comorbidities' contribution to mortality changed since 1987 due to treatment advances. The updated version was validated across international datasets. It supports risk adjustment in hospital abstracts.
Why use separate comorbidity measures?
Elixhauser et al. (1998) in 'Comorbidity Measures for Use with Administrative Data' found comorbidities have independent, varying effects on outcomes across patient groups, so they should not be simplified into one index. Their comprehensive method identifies 30 comorbidities from claims data. This approach improves outcome predictions without prior measure limitations.
Open Research Questions
- ? How can comorbidity indices be further refined to account for evolving treatment effectiveness in predicting long-term outcomes beyond one-year mortality?
- ? What adaptations are needed for clinical practice guidelines to effectively manage multimorbidity patterns identified in primary care populations?
- ? In what ways do specific comorbidity clusters differentially impact healthcare utilization and quality of life in older adults?
- ? How should administrative coding algorithms evolve to capture emerging chronic conditions not covered in ICD-9-CM or ICD-10 standards?
Recent Trends
The field includes 53,439 works with no specified 5-year growth rate available.
Quan et al. noted shifts in Charlson Index weights due to improved chronic disease treatments since 1987.
2011No recent preprints or news coverage from the last 12 months or six months indicate stable focus on validated indices like those from Quan et al. and Elixhauser et al. (1998).
2005Research Chronic Disease Management Strategies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Chronic Disease Management Strategies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers